| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |